First potential immunization against RSV for healthy infants found highly effective in phase 3 trial
by Ann & Robert H. Lurie Children's Hospital of ChicagoTransmission electron micrograph of RSV. Credit: CDC/ Dr. Erskine Palmer / Public DomainNirsevimab showed 74.5 percent efficacy agai
Updated on: February 24,2024
10

First potential immunization against RSV for healthy infants found highly effective in phase 3 trial
by Ann & Robert H. Lurie Children's Hospital of ChicagoTransmission electron micrograph of RSV. Credit: CDC/ Dr. Erskine Palmer / Public DomainNirsevimab showed 74.5 percent efficacy agai
Updated on:February 24,2024
10
